Invictus MD Strategies Corp. (CSE: IMH; OTC: IVITF; FRA: 8IS) has entered into an agreement with Canaccord Genuity Corp. and Eventus Capital Corp. as co-lead underwriters, pursuant to which the underwriters have agreed to purchase, on a bought-deal private-placement basis, 9.1 million units of the company at a price of $1.65 per unit for aggregate gross proceeds to the company of $15,015,000.
The company has agreed to grant the underwriters an overallotment option to purchase up to an additional 1,365,000 units at the offering price, exercisable in whole or in part at any time for a period of 48 hours prior to the closing of the offering. In the event the overallotment option is exercised in full, the aggregate gross proceeds of the offering will be $17,267,250.
Each unit will comprise one common share of the company and one-half of one common share purchase warrant. Each warrant will be exercisable to acquire one common share for a period of 18 months following the closing date of the offering at an exercise price of $2.35 per warrant share. In the event that the company’s daily volume-weighted average share price on the Canadian Securities Exchange (or such other stock exchange the company may be trading on) is greater than $3.75 for 10 consecutive trading days, the company shall, within five days thereafter, issue to the warrantholders a written notice advising of the accelerated expiry of the warrants, which shall not be more than 30 days after the mailing date of such notice. Net proceeds from the offering will be used for expansion plans for the company’s assets and for general working capital purposes.
Closing of the offering is expected to occur on or about March 2, 2017. The offering is in the form of a bought-deal private placement (i) in Canada to accredited investors within the meaning of National Instrument 45-106 and other exempt purchasers in such provinces of Canada, as agreed upon by the issuer and the underwriters; (ii) in the United States in accordance with exemption to the registration requirement under applicable United States securities law; and (iii) outside Canada and the United States on a basis which does not require the qualification or registration of any of the common shares, warrants, warrant shares of the company.
Click here to connect with Invictus MD Strategies Corp. (CSE: IMH; OTC: IVITF; FRA: 8IS).

Trulieve Cannabis Corp. (“Trulieve” or the “Company”) (CSE: TRUL) (OTCQX: TCNNF), a leading and top-performing cannabis company in the United States today announced the appointment of Marcum LLP (“Marcum”) as its independent registered public accounting firm, effective July 5, 2021 . Marcum was appointed following the resignation of MNP LLP (“MNP”) as the Company’s independent registered public accounting firm effective July 5, 2021 .

“We would like to thank MNP for their guidance and expertise over the past two years and we look forward to working with Marcum as the Company’s new independent registered public accounting firm,” stated Chief Financial Officer, Alex D’Amico.

Keep reading... Show less

Cannabis-infused beverages are not a new product concept, but this summer Canadian drink makers hope consumers will discover them for the first time.

Recreational cannabis beverages have beguiled Canadian producers through different avenues, and many continue to make investments. The promise of these drinks lies in the potential of a more welcoming option for new consumers who may be out of their depth with rolled-up dried flower.

Keep reading... Show less

In the news release, BioHarvest Sciences Inc.‘s First Cannabis Cell Reservoir Produces Ongoing Flowering Stage Cannabinoid Cells For 2 Years, issued 07-Jul-2021 by BioHarvest Sciences Inc. over PR Newswire, we are advised by the company that an incorrect version of the release was issued inadvertently. The complete, corrected release follows:

BioHarvest Sciences Inc.‘s First Cannabis Cell Reservoir Produces Ongoing Flowering Stage Cannabinoid Cells For 2 Years

Keep reading... Show less

Trulieve is the first medical cannabis operator to start planting in the state

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today that it commenced operations in West Virginia . The Company has begun cultivation at their 100,000 square foot size facility in Huntington, West Virginia .

Keep reading... Show less

– The Company demonstrates the efficiency and reliability of its BioFarming technology by reducing production cycle time for Cannabis from 14-23 weeks to 3-4 weeks.

– The Company’s BioFarming technology will allow the Company to harvest 13-17 cycles per year versus 2-4 cycles per year for conventional Cannabis agriculture.

Keep reading... Show less